BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

NICE Recommends CSL Vifor’s Sparsentan for Routine Use in Treating IgA Nephropathy in England

CSL Vifor is pleased to announce that the National Institute for Health and Care Excellence (NICE) has published final draft guidance recommending tha...

May 26, 2025 | News

BioMed X and Boehringer Ingelheim Launch Global Call for Next-Gen Intraocular Biologics Platform

The BioMed X Institute announced today the launch of a new global call for research proposals in collaboration with Boehringer Ingelhei...

May 21, 2025 | News

Cell Impact Secures Follow-Up Order for Test Tools from Leading Asian Industrial Player

Cell Impact AB (publ) has signed an agreement to deliver test tools to a leading industrial player in Asia. The deal confirms Cell Impact's attractive offe...

May 20, 2025 | News

Nordic Bioscience Launches nordicEndotrophin™ to Advance Risk Stratification and Monitoring in Fibrosis and Cancer

Nordic Bioscience introduces nordicEndotrophin™, a fully automated high-precision assay that selectively quantifies the intact 77-amino-acid Endotrop...

May 19, 2025 | News

BoomerangFX Launches LeadEngineAI™ Featuring AUVIA™ Across North America, Europe, and Asia-Pacific to Transform Patient Acquisition in Private Healthcare Clinics

BoomerangFX, the leading AI-powered SaaS platform for private-pay healthcare clinics, announced the global launch of LeadEngineAI™, a transform...

May 19, 2025 | News

AGC Biologics Partners with Quell Therapeutics to Advance Treg Cell Therapies for Immune Disorders

-AGC Biologics, your friendly CDMO expert, announced a partnership with Quell Therapeutics (“Quell”), a clinical-stage bio...

May 19, 2025 | News

Eligo Bioscience Secures $5M French Government Grant to Advance Topical Gene-Editing Platform

Funding is part of the call for proposals "Innovations in Biotherapies and Bioproduction," coordinated by the Health Innovation Agency under Fra...

May 14, 2025 | News

iotaMotion Marks International Milestone with First Use of iotaSOFT® System in Zurich Cochlear Implant Study

iotaMotion, Inc., a leader in robotic-assisted systems for cochlear implant surgery, announced the first use of the iotaSOFT® Insertion Syst...

May 14, 2025 | News

Nordic Bioscience and Roche Launch Elecsys PRO-C3 Test to Advance Liver Fibrosis Assessment on cobas Analyzers

Nordic Bioscience announces that its PRO-C3 test is launched by Roche Diagnostics on their cobas analysers. The Roche Elecsys® PRO-C3, used w...

May 09, 2025 | News

India to Gain Faster, Affordable Access to CAR T Therapy as NKure Therapeutics Partners with CRISPR Therapeutics

CTX112™ is an off-the-shelf investigational therapy, offering the potential for faster patient access compared to current CAR T treatments....

May 08, 2025 | News

AGC Biologics Partners with South Korea’s Novelty Nobility to Advance Bispecific Antibody Program Across Europe and Asia

Global CDMO supports South Korean company on a multiphase project at its Copenhagen and Chiba sites AGC Biologics, your friendly CDMO expert, an...

May 06, 2025 | News

Genmab to Submit sBLA for Epcoritamab-R2 Combination in Relapsed/Refractory Follicular Lymphoma Following Positive Phase 3 Data

--Genmab A/S (Nasdaq: GMAB) announced its intention to submit in the first half of 2025 a supplemental Biologics License Application (sBLA) to t...

May 05, 2025 | Regulatory

Aptamer Group and University of Glasgow Partner to Advance Optimer-Based Vaccine Adjuvants for Swine Health

Aptamer Group plc (AIM: APTA), the leading developer of next-generation synthetic binders delivering innovation to the life science industry, has ente...

May 01, 2025 | News

Henlius Licenses Ipilimumab Biosimilar HLX13 to Sandoz in $301M Global Deal

Partnership covers North America, Europe, Japan, and Australia to accelerate global access of HLX13 in immuno-oncology combinations Henlius to receive $...

April 30, 2025 | News

Stay Connected